EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Production of Modified Nucleosides in a Continuous Enzyme Membrane Reactor

Isabel Thiele iD, Heba Yehia iD, Niels Krausch iD, Mario Birkholz iD, Mariano Nicolas Cruz Bournazou iD, Azis Boing Sitanggang iD, Matthias Kraume iD, Peter Neubauer iD, Anke Kurreck

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Isabel Thiele und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 71-76, ACK24, 13355 Berlin, Germany. Hauptthemen laut MEDLINE: Nucleosides, Pentosyltransferases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Academic Exchange Service, DAAD through the GERLS program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleoside analogues are important compounds for the treatment of viral infections or cancers. While (chemo-)enzymatic synthesis is a valuable alternative to traditional chemical methods, the feasibility of such processes is lowered by the high production cost of the biocatalyst. As continuous enzyme membrane reactors (EMR) allow the use of biocatalysts until their full inactivation, they offer a valuable alternative to batch enzymatic reactions with freely dissolved enzymes. In EMRs, the enzymes are retained in the reactor by a suitable membrane. Immobilization on carrier materials, and the associated losses in enzyme activity, can thus be avoided. Therefore, we validated the applicability of EMRs for the synthesis of natural and dihalogenated nucleosides, using one-pot transglycosylation reactions. Over a period of 55 days, 2′-deoxyadenosine was produced continuously, with a product yield >90%. The dihalogenated nucleoside analogues 2,6-dichloropurine-2′-deoxyribonucleoside and 6-chloro-2-fluoro-2′-deoxyribonucleoside were also produced, with high conversion, but for shorter operation times, of 14 and 5.5 days, respectively. The EMR performed with specific productivities comparable to batch reactions. However, in the EMR, 220, 40, and 9 times more product per enzymatic unit was produced, for 2′-deoxyadenosine, 2,6-dichloropurine-2′-deoxyribonucleoside, and 6-chloro-2-fluoro-2′-deoxyribonucleoside, respectively. The application of the EMR using freely dissolved enzymes, facilitates a continuous process with integrated biocatalyst separation, which reduces the overall cost of the biocatalyst and enhances the downstream processing of nucleoside production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleosidesPentosyltransferasesEnzymes, ImmobilizedBiocatalysisDeoxyribonucleosidesPurine-Nucleoside Phosphorylase

Stichwörter der Autor:innen

PID controllerRaspberry Picontinuous enzyme membrane reactor (EMR)halogenated nucleosidesnucleoside analoguespurine nucleoside phosphorylase (PNP)pyrimidine nucleoside phosphorylase (PyNP)thermophilic enzymetransglycosylation

Substanzen

NucleosidesPentosyltransferasesEnzymes, ImmobilizedDeoxyribonucleosidesPurine-Nucleoside Phosphorylase

Autor:innen und Institutionen

  • Department of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 71-76, ACK24, 13355 Berlin, Germany.
  • Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
  • IHP-Leibniz-Institut für Innovative Mikroelektronik, Im Technologiepark 25, 15236 Frankfurt (Oder), Germany.
  • DataHow AG, Hagenholzstrasse.111, 8050 Zurich, Switzerland.
  • Department of Food Science and Technology, IPB University, Kampus IPB Darmaga, Bogor 16680, Indonesia.
  • Department of Chemical and Process Engineering, Technische Universität Berlin, Straße des 17. Juni 135, 10623 Berlin, Germany.

ORCID-Profile: Isabel Thiele, Heba Yehia, Niels Krausch, Mario Birkholz, Mariano Nicolas Cruz Bournazou, Azis Boing Sitanggang, Matthias Kraume, Peter Neubauer

Förderung

  • German Academic Exchange Service
  • DAAD through the GERLS program

Zitieren

APA

Thiele, I., Yehia, H., Krausch, N., Birkholz, M., Cruz Bournazou, M. N., Sitanggang, A. B., Kraume, M., Neubauer, P., & Kurreck, A. (2023). Production of Modified Nucleosides in a Continuous Enzyme Membrane Reactor. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076081

Vancouver

Thiele I, Yehia H, Krausch N, Birkholz M, Cruz Bournazou MN, Sitanggang AB, et al. Production of Modified Nucleosides in a Continuous Enzyme Membrane Reactor. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076081

BibTeX
@article{Thiele2023,
  author = {Thiele, Isabel and Yehia, Heba and Krausch, Niels and Birkholz, Mario and Cruz Bournazou, Mariano Nicolas and Sitanggang, Azis Boing and Kraume, Matthias and Neubauer, Peter and Kurreck, Anke},
  title = {Production of Modified Nucleosides in a Continuous Enzyme Membrane Reactor},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076081}
}
Kostenlos starten →